Many years ago, I began my PhD with the firm resolve of finding a cure for cataracts – not in several years or decades, but within the duration of my PhD. Such was my enthusiasm and naivety. Decades ...

ZOC2017217, an eye drop aimed at slowing or reversing the development of cataracts, is undergoing a pilot study ahead of a ...

A team of researchers at led by University of California, San Diego have developed a new drug in eye drops that can shrink and dissolve cataracts, which may become an alternative to surgery. Cataracts ...

Patients older than 75 years who undergo cataract surgery report more frequent failure of the ocular surface after the procedure than those younger than 65 years; however, the prophylactic ...

Lexitas Pharma Services, a leading full-service ophthalmology clinical research organization (CRO), and Ocusun, a high-tech innovative ophthalmic pharmaceutical company, announced the enrollment of ...

An analysis of past research conducted by the Salt Lake City-based University of Utah Health John A. Moran Eye Center found cause for further testing to determine if cataracts might someday be ...

A regimen that spares patients recovering from cataract surgery the burden of using antibacterial and anti-inflammatory eye drops several times a day for weeks and instead uses an injection to ...

Every year, nearly 700,000 people in England have cataracts removed, making it one of the most common ops in the country. The procedure, which replaces the eye’s lens after it grows cloudy over time, ...

Known to be most common causes of loss of vision in people above the age of 40, cataract is the most common cause of blindness around the world. Apart from causing complete blindness, cataract makes a ...

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.